To cite this paper use one of the standards below:
INTRODUCTION AND OBJECTIVES: Anaplastic thyroid carcinoma (ATC) is a subtype of thyroid cancer (TC) characterized by rapid tumor progression and poor prognosis. Osteopontin (OPN) activates tumor progression in several tumor types, including TC. Our previous findings indicated that the OPNa splice variant is overexpressed in thyroid tumors and induces tumor progression features. However, the molecular mechanisms by which OPNa promotes these effects are poorly understood. Investigating whether integrin and/or CD44 receptors can mediate OPNa effects on distinct aspects related to tumor progression. MATERIAL AND METHODS: The expression of αvβ3 integrin and CD44 surface receptors was evaluated by flow cytometry in the 8505c ATC cell line stably overexpressing OPNa (8505c-OPNa+). OPN levels secreted into the conditioned medium (CM) from 8505c-OPNa cells was quantified by ELISA assays. The wild-type (wt)-8505c cell line was tested for cell growth, migration, and invasion rates in response to cell culturing in the presence of conditioned media (CM) secreted by 8505c-OPNa+cells. RESULTS AND CONCLUSION: The expression of αvβ3 integrin and CD44 receptors was detected on the 8505c-OPNa+ cell surface but was not differentially expressed in relation to control cells. We also found that CM secreted from 8505c-OPNa+ cells induces an increase in cell growth, migration and invasion rates of wt-8505c cells. Notably, the neutralization of the αvβ3 receptor using an anti- αvβ3 integrin specific antibody inhibited their invasive and migration potential. Taken together, these findings support the notion that OPNa secreted by the 8505c-OPNa+ cells may impact key functional aspects of ATC progression and that cell invasion and migration could be mediated by the αvβ3 integrin receptor in this tumor model.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper